New Radiation Shielding Superior to Lead for CT Scans
New custom-designed patient shielding devices should supplant traditional lead aprons for chest CT scans - and possibly every scan, regardless of body part. That’s according to the authors of a new study published in the British Journal of Radiology.
New custom-designed patient shielding devices should supplant traditional lead aprons for chest CT scans - and possibly every scan, regardless of body part. That’s according to the authors of a new study published in the British Journal of Radiology.
Medical physicist Gareth Iball, MSc, and colleagues at the Leeds General Infirmary used dosimeters to measure radiation levels throughout the abdomen and pelvis during chest CT scans of a RANDO phantom. Dose measurements were made with no shielding, with lead aprons and with the new shield around the abdomen and pelvis to quantify the achievable organ and effective dose reductions.
With the new out-of-plane shielding devices in place, Ball and colleagues measured “significant dose savings” throughout the abdomen and pelvis. All told, the new shielding provided effective dose saving of 4 percent over that obtained through conventional lead aprons.
“This could yield significant population dose savings and reductions in collective radiation risk,” the authors wrote.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
